Page last updated: 2024-08-18

2-naphthol and bortezomib

2-naphthol has been researched along with bortezomib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baggio, R; El Oualid, F; Fasci, D; Hedstrom, L; Lawson, AP; Long, MJC; Qian, Y; Rozhansky, L; Weerapana, E1
Duhamel, LA; Eskandarpour, M; Flanagan, AM; Presneau, N; Tirabosco, R; Ye, H1

Other Studies

2 other study(ies) available for 2-naphthol and bortezomib

ArticleYear
Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor.
    Bioorganic & medicinal chemistry letters, 2019, 01-15, Volume: 29, Issue:2

    Topics: Carbonates; Deubiquitinating Enzymes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Ubiquitination

2019
Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas.
    British journal of cancer, 2017, Jul-25, Volume: 117, Issue:3

    Topics: AMP-Activated Protein Kinase Kinases; Anoikis; Antineoplastic Agents; Benzamides; Bone Neoplasms; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; MicroRNAs; Naphthols; Osteosarcoma; Protein Biosynthesis; Protein Serine-Threonine Kinases; RNA, Messenger; Signal Transduction; Sirtuin 1; TOR Serine-Threonine Kinases; Transfection

2017